scispace - formally typeset
Open AccessJournal ArticleDOI

Pregnancy in women with pulmonary hypertension

Petronella G. Pieper, +1 more
- 09 Nov 2011 - 
- Vol. 19, Iss: 12, pp 504-508
TLDR
Pregnancy should still be regarded as contraindicated in women with pulmonary hypertension, and pregnancy and delivery should be managed by multidisciplinary services with experience in the management of both pulmonary hypertension and high-risk pregnancies.
Abstract
Women with pulmonary hypertension have a high risk of morbidity and mortality during pregnancy. The inability to increase cardiac output leads to heart failure while further risks are introduced with hypercoagulability and decrease in systemic vascular resistance. There is no proof that new advanced therapies for pulmonary hypertension decrease the risk, though some promising results have been reported. However, pregnancy should still be regarded as contraindicated in women with pulmonary hypertension. When pregnancy occurs and termination is declined, pregnancy and delivery should be managed by multidisciplinary services with experience in the management of both pulmonary hypertension and high-risk pregnancies.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute

TL;DR: This guideline document sought to discuss the state of knowledge of pregnancy effects on pulmonary vascular disease and to define usual practice in avoidance of pregnancy and pregnancy management, and drafted 38 consensus-based recommendations on pregnancy avoidance and management.
Journal ArticleDOI

Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening.

TL;DR: Pregnant women are susceptible to COVID-19, and special attention should be paid to the selection of drugs that are both effective for maternal diseases and friendly to the fetus, and drugs that show superior maternal and fetal safety are worthy of consideration.
Journal ArticleDOI

Épidémiologie de la mortalité maternelle en France, 2007–2009

TL;DR: Maternal mortality is rather stable in France and may reach more reduction as deaths due to atony decreased as suboptimal care did, but the haemorrhages are the leading cause but their ratio is 1.9 versus 2.5 previously; this decrease results from the postpartum haem orrhage by uterine atony going down.
Journal ArticleDOI

Pulmonary Hypertension and Pregnancy Outcomes: Insights From the National Inpatient Sample

TL;DR: In a contemporary data set of pregnant women in the United States, PH was associated with an increase in MACE during the hospitalization for delivery, with an exceptionally elevated risk among women with associated cardiomyopathy.
Journal ArticleDOI

Pregnancy and pulmonary hypertension.

TL;DR: A systematic review of the literature on the use of targeted treatments for pulmonary arterial hypertension during pregnancy indicates a considerable decrease of mortality since a previous review in 1998, and a further non-significant decrease since the latest review in 2009.
References
More filters
Journal ArticleDOI

ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC).

TL;DR: Recommendations for the prevention and management of venous thrombo-embolism in pregnancy and puerperium and the associated risk groups according to risk factors: definition and preventive measures are presented.

ESC Guidelines on the management of cardiovascular diseases during pregnancy The Task Force on the Management of Cardiovascular Diseases

TL;DR: In this paper, the authors presented a list of risk factors for venous thrombo-embolism in pregnancy and puerperium in women with heart disease, including the following risk factors: hypertension, congestive heart failure, hypertension, age (>75 years), diabetes, stroke, and atrial septal defect.
Journal ArticleDOI

Prospective Multicenter Study of Pregnancy Outcomes in Women With Heart Disease

TL;DR: Pregnancy in women with heart disease is associated with significant cardiac and neonatal complications, despite state-of-the-art prenatal care, and the cardiac event rate can be predicted using a risk index incorporating these predictors.
Related Papers (5)

ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC).